Cvs Health Stock Price Target
Leerink partners analyst stephen tanal maintained a hold rating on cvs health corp on thursday, setting a price target of $73, which is approximately 12.34% above the present share price of $64.98.
Cvs health stock price target. The company's pharmacy services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. Cvs health (nyse:cvs) had its target price reduced by investment analysts at deutsche bank aktiengesellschaft from $104.00 to $101.00 in a report released on monday, the fly reports. This is 2.47% more than the trading day before monday, 23rd nov 2020.
Cvs health (nyse:cvs) had its target price upped by equities researchers at piper sandler from $72.00 to $76.00 in a report issued on wednesday, the fly reports. Cvs has a lower variance in analysts' estimates than 32.57% of all us stocks. Based on analysts offering 12 month price targets for cvs in the last 3 months.
The new note on the price target was released on september 27, 2019, representing the official price target for cvs health corporation stock. The institutional investor owned 8,051 shares of the pharmacy operator’s stock after purchasing an additional 402 shares during the quarter. In terms of volatility of its share price, cvs is more volatile than only 2.15% of stocks we're observing.
Net sales (including intragroup) break down by activity as follows: The firm currently has a “buy” rating on the pharmacy operator’s stock. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.
Their forecasts range from $66.00 to $101.00. With a market capitalization of $91,139,646,866, cvs health corp has a greater market value than 97.69% of us stocks. Find the latest cvs health corporation (cvs) stock quote, history, news and other vital information to help you with your stock trading and investing.
Previously, the target price had yet another raise to $75, while credit suisse analysts kept a outperform rating on cvs stock. Cvs has a higher average analyst price target than 83.64% of healthcare stocks. The average true range (atr) for cvs health corporation is set at 1.42, with the.